Back to top

KYMR Downgraded by RBC Capital -- Price Target Raised to $115

KYMR Downgraded by RBC Capital -- Price Target Raised to $115

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kymera Therapeutics, Inc. (KYMR)